GenMont (3164.TW) monthly revenue, September 2026
GenMont reported revenue of NT$0.05bn for September 2026, up 50.4% from the previous month and up 46.9% from a year earlier. Year-to-date revenue was NT$0.30bn, down 1.5% year on year. It ranked 24 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.05 | 50.4 | 46.9 |